Spandana Sphoorty Financial Ltd Q1 FY27 Results

The headline profit of ₹11.9 crore looks stellar — up 103% YoY from Q4 FY26's ₹5.8 crore. But the call reveals the catch: the quarter included ₹51 crore in recoveries from the aged 90-plus loan pool, plus ₹24 crore in write-off recoveries. Strip those out, and the core pre-provision operating profit sits at roughly ₹16 crore — a fragile base on which to build the company's 3.5% ROA ambition for FY28.

More troubling: revenue fell 5.5% year-on-year to ₹283.9 crore, even as AUM grew 11% quarter-on-quarter to ₹4,887 crore. Spandana grew the balance sheet but shrank the top line — a gap management did not directly address. The narrative pivoted to AUM and collection metrics, leaving the revenue stall unexplained.

The recovery pool narrative is central to understanding the quarter. Management flagged a ₹2,500 crore pool of aged 90-plus loans from prior cycles. In Q1, collections from this pool hit ₹51 crore — a non-recurring windfall. Management guided for ₹150–200 crore in FY27 recoveries, but the quarterly pace suggests this target assumes acceleration. More critically, this pool is a declining asset. Management's own words: "The older 90-plus, we will not collect. But of course, you will have some 90-plus this year also. So those collections will always remain. The older pool will stop starting next year onwards."

Profitability is thus hostage to recovery acceleration. Without it, quarterly PPOP reverts to the low tens of crores, and the net profit margin of 3.9% becomes entirely dependent on credit cost discipline — a high-wire act when the loan book is under stress from weak monsoon and El Niño conditions.

ROA target clarity. Management explicitly guided for 3.5% return-on-assets by FY28 — a new quantification. Current ROA is 1% (Q1). Hitting 3.5% in 12 months requires 250 basis points of expansion, which implies net profit margin must widen to 4.5%–5% on the back of higher AUM. The mechanism is clear (yield stabilization at 25.25%, cost of funds compression, OpEx held to ₹675 Cr), but Q1 delivery (NPM 3.9%, revenue stall) does not yet corroborate the trajectory.

Cost of funds improving faster. Marginal cost of borrowing (MCB) declined 70 basis points to 11.3% (vs 12% prior quarter). Overall cost of deposits fell 40 basis points to 12.8%. This is fueled by a recent rating upgrade and ₹545 crore in Credit Guarantee Scheme (MFI) sanctions (₹200 Cr drawn at ~10% pricing). The company is explicitly weaponizing cheaper funding to expand NIM; this is a tangible upgrade.

Branch expansion narrative flipped. Prior call had emphasized consolidation and branch rundown. This quarter, management signaled a shift: 1,250 branches are held stable, and new geographies are targeted (Tamil Nadu base ₹16 Cr expanding into a ₹38,000 Cr market; Maharashtra doubling to 2% market share). A new Chief Business Officer for the South was hired. This is strategic repositioning, not just cost cuts.

90-plus recovery pool guidance explicated. Prior calls mentioned recovery efforts; this call quantified it: ₹2,500 Cr pool, ₹150–200 Cr target for FY27 (vs ₹51 Cr in Q1; ₹326 Cr collected over 18 months). This implies acceleration is needed for the guidance to hold. If quarterly pace (~₹50 Cr) sustains, FY27 will net ~₹200 Cr — hitting the top end. But it's an execution risk, and it's a declining asset.

The market reaction was immediate and negative. The stock fell 10.52% on day 1 of the result announcement and continued to slide to -11.1% by day 5. At ₹261.1 (as of August 1, 2026), the stock is now trading 18.25% below its all-time high of ₹319.4 — a sharp drawdown that has pushed RSI to 29.5 (oversold territory). The sell-off mirrors the fundamental read: growth in the balance sheet is not translating to earnings growth, and recovery-dependent profitability has lost credibility.

Ownership data shows institutional appetite cooling. FII holdings trimmed by 46 basis points quarter-on-quarter to 19.89%, while DII holdings remained flat at 5.79%. Promoters hold steady at 48.14%. Recent bulk/block activity (NK Securities buy/sell at ₹266.42–₹266.58) is typical market-making. The price action and ownership shift together suggest that the fundamental story—recovery-dependent profits, revenue stall, margin pressure—has tested institutional patience.

The oversold RSI and 18% drawdown from ATH do create a technical opportunity for value-oriented buyers. But the discount is deserved until management demonstrates that organic (non-recovery) profitability is improving and revenue headwinds are reversing.

The honest read: Spandana is well-run — collection discipline, cost management, and funding access are genuine strengths. But this quarter's profitability is a mirage built on an aging recovery pool, and the revenue stall is a red flag that growth is hitting ceiling. The 3.5% ROA target for FY28 is mathematically feasible but operationally uncertain. Execution matters enormously over the next 2–3 quarters: LOS migration must go smoothly, individual product must gain traction, and organic profit must stabilize. Until then, the stock deserves its discount.

Strip recoveries. That's it. The organic PAT (ex-90-plus pool and write-off recoveries) is the ground truth for Spandana's earning power. Until management can deliver consistent double-digit crore profits without the recovery boost, the profitability thesis remains hostage to a declining asset. Watch for Q2 organic PAT (or ask for it in calls). That single number will tell you whether the company is executing operationally or just harvesting a legacy pool.